Trials / Completed
CompletedNCT05864079
Developmental Endothelial Locus-1, Platelet Count, and Soluble P-selectin in Overweight and Obese Subjects
Serum Levels of Developmental Endothelial Locus-1 and Its Relationship With Platelet Count and Soluble P-selectin in Overweight and Obese Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This observational study aims to detect serum levels of Developmental Endothelial Locus-1 (DEL-1), Platelet Count, and Soluble P-selectin (sP-sel) in Overweight and Obese Subjects. The main questions it aims to answer are: * Is there a difference in serum DEl-1 levels in overweight and obese subjects compared to normal subjects? * Are there any relations between serum DEL-1 levels, sP-sel, and platelet count in overweight and obese subjects ?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Platelet count | Platelet count in study groups |
| DIAGNOSTIC_TEST | Developmental endothelial locus-1 (DEL-1) | Serum DEL-1 in study groups |
| DIAGNOSTIC_TEST | soluble P-selectin (sP-sel) | Serum sP-sel in study groups |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-02-01
- Completion
- 2024-04-01
- First posted
- 2023-05-18
- Last updated
- 2024-06-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05864079. Inclusion in this directory is not an endorsement.